The global intraocular lens market is experiencing sustained momentum driven by the increasing prevalence of cataracts, growing adoption of premium and multifocal lenses, and continuous advances in ...
JACKSONVILLE, Fla.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) announced U.S. Food and Drug Administration (FDA) approval of TECNIS PureSee IOL, an extended depth of focus (EDOF) intraocular lens ...
Medi-Tech Insights estimates that the global intraocular lens market will reach a value of $3.9 billion in 2021 and expand at a rate of 5% to 6% annually over the next five years. The global growth in ...
Intraocular lenses (IOLs), implanted in the eye as treatment for cataracts or myopia, are a growing global market in an ageing population, one estimated to be worth more than $4.5 billion by 2022.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results